We have collected information about Novel Ophthalmic Drug Delivery Technology for you. Follow the links to find out details on Novel Ophthalmic Drug Delivery Technology.
https://www.liebertpub.com/doi/abs/10.1089/jop.2019.0135
Sufficient ophthalmic drug delivery is still challenging for pharmaceutical technologists, despite various scientific efforts. Several ocular drug carriers have been designed to enhance bioavailabi...
http://ijpsr.com/bft-article/a-novel-ophthalmic-drug-delivery-system-in-situ-gel/?view=fulltext
The ophthalmic in-situ gels now days proved an palpable sustained drug delivery in various eye diseases. The formulation of in-situ gels for eye which carries the advantages like easy for administration, reduces frequency of dose and improves patient compliance.
https://seekingalpha.com/article/3924046-eyegates-novel-technology-revolutionize-ophthalmic-drug-delivery
Feb 24, 2016 · Current drug delivery via drops and injections are inefficient and invasive. Eyegate's technology is in Phase 3 study for anterior uveitis. If results are positive, will be used to support NDA.
http://ijpsr.com/bft-article/current-and-novel-techniques-in-the-ophthalmic-drug-delivery-systems/?view=fulltext
Novel Ophthalmic Dosage Forms: Colloidal Systems: The colloidal systems in ocular drug delivery include nanoparticles, liposomes, Nano emulsions, microemulsion etc. The advantages of colloidal systems include controlled and sustained release of drug at the targeted site, ability to overcome blood ocular barriers,...
https://www.ondrugdelivery.com/wp-content/uploads/2017/05/ONdrugDel-Ophthalmic-Drug-Delivery-63-Jan-2016-EmulTech.pdf
micro-encapsulation process, and its suitability as a particle formation technology for enhancing and enabling injectable ophthalmic pharmaceutical products. IMPROVING OPHTHALMIC DRUG DELIVERY WITH NOVEL EMULSION TECHNOLOGIES FOR STERILE SUSTAINED-RELEASE INJECTABLES “Encapsulation in biodegradable matrices is used for controlling the
https://www.dsm.com/biomedical/en_US/media-events/press-releases/2018/2018-08-01-aeri-pharmaceuticals-dsm-biomedical-expand-collaboration-agreement.html
Aug 01, 2018 · Aerie Pharmaceuticals, Inc. and DSM Biomedical, Inc. expand collaboration agreement focused on novel drug delivery technology in ophthalmology Exton PA, US, 01 Aug 2018 12:30 CEST Promising technology platform to potentially deliver therapies to treat a broad spectrum of ophthalmic …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061492/
Topical instillation of ophthalmic drops is the most common method used to administer pharmaceutical agents for ocular disease; 90% of ophthalmic drug formulations are for topical drop use. Methods of topical drug delivery include eye drops, ointments, suspensions, contact lenses, and some drug delivery devices.Author: Henry F. Edelhauser, Cheryl L. Rowe-Rendleman, Michael R. Robinson, Daniel G. Dawson, Gerald J. Chad...
http://www.thepharmajournal.com/vol1Issue12/Issue_feb_2013/1.1.pdf
Ocular drug delivery is one of the most challenging tasks faced by Pharmaceutical researchers. Major barriers in ocular medication are the ability to maintain a therapeutic level of the drug at the site of action for a prolonged duration. The ophthalmic preparations …
https://www.ondrugdelivery.com/new-solutions-ophthalmic-drug-delivery-using-biodegradable-silica-matrix/
Mika Jokinen, Cora Griffin and Lasse Leino describe the novel opportunities that biodegradable silica matrix technology offers to ophthalmic drug delivery. Due to the ageing population, chronic ocular diseases are becoming more common, and the number of patients suffering from conditions such as age-related macular degeneration (AMD), glaucoma, dry eye and diabetic retinopathies is increasing steadily.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289909/
To overcome the ocular drug delivery barriers and improve ocular bioavailability, various conventional and novel drug delivery systems have been developed such as emulsion, ointments, suspensions, aqueous gels, nanomicelles, nanoparticles, liposomes, dendrimers, implants, contact lenses, nanosuspensions, microneedles, and in situ thermosensitive gels for the earlier mention ocular …Author: Ashaben Patel, Kishore Cholkar, Vibhuti Agrahari, Ashim K Mitra
Searching for Novel Ophthalmic Drug Delivery Technology?
You can just click the links above. The data is collected for you.
